Navigation Links
ARIUS Announces Third Quarter Fiscal 2007 Financial Results
Date:10/12/2007

Cumulative

Three-month Three-month since

period ended period ended inception on

August 31, August 31, August 11,

2007 2006 1999

$ $ $

-------------------------------------------------------------------------

Revenue:

Research Contract 508,660 - 508,660

Product 42,456 - 98,942

Licensing fees 165,012 208,564 3,284,703

Research grant payments - 18,146 273,663

-----------------------------------------------------------------------

716,128 226,710 4,165,968

Expenses:

Research and development,

net of tax credits 2,402,060 1,303,088 23,254,226

General and administrative 1,160,827 470,619 10,519,592

Interest expense 667 198,260 903,836

-----------------------------------------------------------------------

3,563,554 1,971,967 34,677,654

-----------------------------------------------------------------------

Loss before the undernoted (2,847,426) (1,745,257) (30,511,686)

Interest income 155,721 275,529 1,902,963

Loss on extinguishment of debt - - (782,143)

-------------------------------------------------------------------------

Loss before income taxes (2,691,705) (1,469,728) (29,390,866)

Income taxes:

Current
'/>"/>

SOURCE ARIUS Research Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Streptococcus salivarius
2. Streptococcus salivarius
3. Speaker announces business members of IT Task Force
4. Doyle announces technology tax credits for Berbee
5. Doyle announces new energy, global warming policies
6. Doyle announces $80M renewable energy strategy
7. GE announces first installation of Discovery VCT
8. UWM announces winners of RGI awards
9. Third Wave announces two senior management appointments
10. Mirus announces new method for making antibodies
11. Merge announces sofware updates, upcoming acquisition

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...rstCall/ -- BioSpecifics Technologies Corp. (Nasda... first-in-class collagenase-based products, today ...ter ended September 30, 2009. ,, "We were extr...DA,s Arthritis Advisory Committee unanimously reco...X(TM) for the treatment of Dupuytren,s disease, an...
(Date:11/6/2009)...-FirstCall/ -- ,, 3Q09 Corporate Highlights:...arketing Authorization to Astellas Pharma Europe L...iness activities Expanded management team to incl...ctor, Commercial Operations Appointed Bradford S....chairman , Upcoming 2009 Milestones: ,...
(Date:11/6/2009)...rowhead’s 2010 Personalized Medicine Partner...bruary 22-24, 2010 in Philadelphia, has been annou...ht key issues in forming partnerships and engage t... Minneapolis, MN (PRWEB) Nove...2010 Personalized Medicine Partnerships Conference...
(Date:11/5/2009)... -- DSM Pharmaceutical Products today announced th...ix, Saint Jean D,Illac, France, where DSM will be ...er for Galenix commercial products on a global bas...ness development opportunities co-marketing Galeni...h of Galenix in drug product development and clini...
Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3
...DNA polymerase for robust, high-fidelity PCR,amp... Nielson Valerie,Hedden Connie Hansen Janice ...k Madden ,Stratagene , Stratagene announces th...roved version of Pfu DNA polymerase for high-fide...cloned Pfu DNA,polymerase and a novel thermostab...
... , Novel Herculase Hotstart DNA polymeras... ,, , Michael Borns...ene ,, Stratagenes Herculase , ... enzyme for difficult PCR applications, particula...copy number, or GC-rich templates. We have expande...
... and native eukaryotic amino acid sequence , ,...ems, Inc. , The ESP LIC cloning and expression s...f recombinant proteins in yeast. This system uses,... and directional cloning of PCR,products immedia...GST),purification tag and the recognition site f...
Other Biology Technology:Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase 2Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase 3Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase 4Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase 5Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase 6Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase 7Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase 8Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase 9Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase 10Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase 11The Best Enzyme for the Toughest PCR Challenges Improved with New Hot-Start Feature 2The Best Enzyme for the Toughest PCR Challenges Improved with New Hot-Start Feature 3New Yeast Cloning System for Producing Proteins with Native Amino Acid,Sequences 2New Yeast Cloning System for Producing Proteins with Native Amino Acid,Sequences 3New Yeast Cloning System for Producing Proteins with Native Amino Acid,Sequences 4New Yeast Cloning System for Producing Proteins with Native Amino Acid,Sequences 5
(Date:11/5/2009)...hers (NABT) will recognize Leonard C. Yannielli, p...y Community College (NVCC) in Waterbury, Connectic... the NABT annual professional development conferen...ado. , The Evolution Education Award is cosponso...es,(AIBS) and Biological Sciences Curriculum Stud...
(Date:11/4/2009)... Long Beach and Riverside are responsible for a si...ma, and the true impact of air pollution and ship ...mated, according to researchers at the University ...h appears in an online edition of the American Jo...nt of all childhood asthma cases in Long Beach and...
(Date:11/4/2009)...ewswire/ -- Spectros, developer and manufacturer o...hich shed light on life-threatening diseases, anno...ion deals for both its T-Stat® VLS Tissue Oxi...stralia, New Zealand, The Netherlands, Belgium, L...n, Portugal, Poland, Greece, Turkey, and Russia. ...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2USC study finds big air pollution impacts on local communities 2Spectros Signs New International Distribution Deals 2Imagenetix Inc Reports Year End Results 49281 1Imagenetix Inc Reports Year End Results 49281 2Imagenetix Inc Reports Year End Results 49281 3Imagenetix Inc Reports Year End Results 49281 4Imagenetix Inc Reports Year End Results 49281 5Chiltern Expands European Operations With a New Office in Belgium 49279 1Chiltern Expands European Operations With a New Office in Belgium 49279 2Health Care Service Corporation Names Carolyn H Clift as Senior Vice President and First Chief Diversity Officer 49277 1Health Care Service Corporation Names Carolyn H Clift as Senior Vice President and First Chief Diversity Officer 49277 2
...n experimental RNA-based drug -- the first of its ...and then springs into action to destroy them, whil...oped at Duke University Medical Center, uses one t...enter cancer cells, and another type, called silen... keeps the cells alive. , In tests in mice with ...
... through a laboratory version of boot camp may hel...niversity of Pittsburgh researchers. In essence, t...l therapeutic vaccine loaded with a patient,s own ...zed to rally other cells of the immune system in f... the XVI International AIDS Conference (AIDS 2006)...
...t of Ophthalmology,s Schepens Eye Research Institu...are the first to learn why the cornea, the clear w...ue phenomenon that makes vision possible. The key,...f large amounts of the protein VEGFR-3 (vascular e...ithelial layer of normal healthy corneas. Accordin...
Other Biology News:Experimental RNA-based drug kills prostate cancer cells effectively and safely 2T cells activated to fight HIV basis for dendritic cell therapeutic vaccine 2T cells activated to fight HIV basis for dendritic cell therapeutic vaccine 3Scientists discover why cornea is transparent and free of blood vessels, allowing vision 2Scientists discover why cornea is transparent and free of blood vessels, allowing vision 3
Silencer Pre-designed siRNA, PAGE purified, annealed from Ambion
...are designed to rapidly and reliably amplify unkno... APAgene provides hassle-free, ready-to use compon... necessary ingredients are provided in each kit. T...t-end amplification of large clones such as P1, YA...
Rabbit Anti-Yaf9 Polyclonal Antibody, Unconjugated from Abcam
...is designed to deparaffinize and perform Heat Indu...affin-embedded tissue sections mounted on glass mi...by melting the paraffin at the high temperature us...ation of the paraffin by detergent. Formaldehyde f...
Biology Products: